How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code NGZ: Susceptibility Test Plate, Antifungal. View classification details, related manufacturers, 510(k) clearances, and recall records.
The device is an in vitro diagnostic device intended for use in determining quantitative susceptibility of Candida species to various antifungal agents diluted in varying concentration in a microtiter plate format.Explore microbiology records →
21 clearance records and 5 recall records in the covered releases, across 7 source company names and 1 product codes. Dated history runs from Oct 9, 2001 to Oct 19, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 1 |
| April 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 0 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 0 | 1 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| NGZ · Susceptibility Test Plate, Antifungal | 21 | 5 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| Yeastone Broth, 11ML, 10/BOX, used in antibiotic susceptibility testing of mycological clinical specimensZ-0355-2027 · NGZ | Remel, Inc | Recall | Nov 3, 2026FDA classification date |
| Yeastone Broth, 11ML, 10/BOX YY3462Z-1806-2026 · NGZ | Remel, Inc | Recall | Apr 10, 2026FDA classification date |
| The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mLK243738 · NGZ | Thermo Fisher Scientific | 510(k) | Feb 27, 2025FDA decision date |
| VITEK 2 AST-Yeast Voriconazole (<= 0.03125 - >= 4 µg/mL)K232967 · NGZ | bioMerieux, Inc. | 510(k) | Jun 12, 2024FDA decision date |
| VITEK 2 AST-Yeast Anidulafungin (<= 0.015 - >= 8 µg/mL)K232963 · NGZ | bioMerieux, Inc. | 510(k) | Jun 7, 2024FDA decision date |
| The Sensititre YeastOne Susceptibility System with Rezafungin in the dilution range of 0.008-8ug/mLK231433 · NGZ | Thermo Fisher Scientific | 510(k) | Aug 31, 2023FDA decision date |
| Sensititre YeastOne Susceptibility System with Fluconazole in the dilution range of 0.12-128ug/mLK221198 · NGZ | Thermo Fisher Scientific | 510(k) | Mar 10, 2023FDA decision date |
| The Sensititre YeastOne Susceptibility System with Caspofungin in the dilution range of 0.015-16ug/mlK221899 · NGZ | Thermo Fisher Scientific | 510(k) | Jan 20, 2023FDA decision date |
| VITEK 2 REAGENT AST-GP67 TEST KIT 20 CARDS, CATALOG 22226Z-0792-2023 · NGZ | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| ETEST CLINICAL FLUCONAZOLE FL 256 US S30, CATALOG 412333Z-0824-2023 · NGZ | Biomerieux Inc | Recall | Jan 4, 2023FDA classification date |
| Sensititre YeastOne Susceptibility System with Voriconazole in the dilution range of 0.008 - 8 ug/mLK211539 · NGZ | Thermo Fisher Scientific | 510(k) | Dec 15, 2021FDA decision date |
| VITEK 2 AST-YS Micafungin (<=0.06 - =>8 µg/mL)K181368 · NGZ | bioMerieux, Inc. | 510(k) | Jun 20, 2018FDA decision date |
| VITEK 2 Gram Fungal Susceptibility card (AST-YS05), REF 411945, 20 cards per carton.Z-2378-2017 · NGZ | Biomerieux Inc | Recall | May 22, 2017FDA classification date |
| VITEK 2 AST-Yeast Micafungin (0.06-8 mcg/mL)K151923 · NGZ | bioMerieux, Inc. | 510(k) | Mar 25, 2016FDA decision date |
| VITEK 2 AST-YS Caspofungin <=0.125 - >=8 ug/mLK151817 · NGZ | bioMerieux, Inc. | 510(k) | Feb 18, 2016FDA decision date |
| VITEK 2 AST YS FLUCYTOSINE, VITEK 2 AST YEAST FLUCYTOSINEK133952 · NGZ | bioMerieux, Inc. | 510(k) | Aug 19, 2014FDA decision date |
| VITEK 2 AST - YEAST FLUCONAZOLEK133817 · NGZ | bioMerieux, Inc. | 510(k) | Aug 5, 2014FDA decision date |
| SENSITITRE YEASTONE SUSCEPTIBILITY PLATESK133038 · NGZ | Trek Diagnostic Systems | 510(k) | Jan 31, 2014FDA decision date |
| VITEK 2 YEAST CASPOFUNGINK101566 · NGZ | bioMerieux, Inc. | 510(k) | Sep 28, 2010FDA decision date |
| VITEK 2 YEAST VORICONAZOLEK092454 · NGZ | bioMerieux, Inc. | 510(k) | May 21, 2010FDA decision date |
| ETEST VORICONAZOLE 0.002-32 UG/MLK082534 · NGZ | Ab Biomerieux | 510(k) | Nov 2, 2009FDA decision date |
| SENSITITRE YEASTONE SUSCEPTIBILITY PLATESK090968 · NGZ | Trek Diagnostic Systems, Inc. | 510(k) | Jun 4, 2009FDA decision date |
| SENSITITRE YEASTONE SUSCEPTIBILITY PLATES- ADDITIONAL ANTIMICROBICSK081063 · NGZ | Trek Diagnostic Systems, Inc. | 510(k) | Mar 6, 2009FDA decision date |
| VITEK 2 AST-YS FLUCONAZOLEK061945 · NGZ | bioMerieux, Inc. | 510(k) | Sep 19, 2006FDA decision date |
| ETEST FOR ANTIFUNGAL SUSCEPTTIBILITY TESTINGK040560 · NGZ | Ab Biodisk | 510(k) | Jul 27, 2004FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 21, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 21, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.